New federal signals and Big Pharma interest set the stage as Horizons comes back to New York. Here’s what DMV residents should watch, and how policy, access, and culture may evolve next.

Resilient Pharmaceuticals submits a renewed application for MDMA-assisted PTSD therapy, seeking FDA approval without a fresh Phase 3 trial.

Resilient resubmits MDMA-assisted therapy to FDA, Definium reports positive oral LSD Phase 3 data in GAD, and Canada funds a C$24M cannabis–brain health consortium.